<VariationArchive VariationID="916539" VariationName="NM_015311.3(OBSL1):c.[1273dup];[35dup]" VariationType="CompoundHeterozygote" Accession="VCV000916539" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2020-12-03" MostRecentSubmission="2020-12-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="916539">
      <SimpleAllele AlleleID="192467" VariationID="195306">
        <GeneList>
          <Gene Symbol="OBSL1" FullName="obscurin like cytoskeletal adaptor 1" GeneID="23363" HGNC_ID="HGNC:29092" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2q35</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219547206" stop="219571539" display_start="219547206" display_stop="219571539" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220415449" stop="220436267" display_start="220415449" display_stop="220436267" Strand="-" />
            </Location>
            <OMIM>610991</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_015311.3(OBSL1):c.1273dup (p.Thr425fs)</Name>
        <CanonicalSPDI>NC_000002.12:219568063:T:TT</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>2q35</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219568063" stop="219568064" display_start="219568063" display_stop="219568064" variantLength="1" positionVCF="219568063" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220432785" stop="220432786" display_start="220432785" display_stop="220432786" variantLength="1" positionVCF="220432785" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        </Location>
        <OtherNameList>
          <Name>p.Thr425AsnfsTer40</Name>
        </OtherNameList>
        <ProteinChange>T425fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.220432786dup" Assembly="GRCh37">
              <Expression>NC_000002.11:g.220432786dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.219568064dup" Assembly="GRCh38">
              <Expression>NC_000002.12:g.219568064dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_016977.1" sequenceAccession="NG_016977" sequenceVersion="1" change="g.8483dup">
              <Expression>NG_016977.1:g.8483dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001173408.2" sequenceAccession="NM_001173408" sequenceVersion="2" change="c.1273dup">
              <Expression>NM_001173408.2:c.1273dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001166879.1" sequenceAccession="NP_001166879" sequenceVersion="1" change="p.Thr425fs">
              <Expression>NP_001166879.1:p.Thr425fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001173431.2" sequenceAccession="NM_001173431" sequenceVersion="2" change="c.1273dup">
              <Expression>NM_001173431.2:c.1273dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001166902.1" sequenceAccession="NP_001166902" sequenceVersion="1" change="p.Thr425fs">
              <Expression>NP_001166902.1:p.Thr425fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015311.3" sequenceAccession="NM_015311" sequenceVersion="3" change="c.1273dup" MANESelect="true">
              <Expression>NM_015311.3:c.1273dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_056126.1" sequenceAccession="NP_056126" sequenceVersion="1" change="p.Thr425fs">
              <Expression>NP_056126.1:p.Thr425fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015311.2" sequenceAccession="NM_015311" sequenceVersion="2" change="c.1273dupA">
              <Expression>NM_015311.2:c.1273dupA</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-02-23" DateCreated="2011-01-25" MostRecentSubmission="2024-06-20" NumberOfSubmissions="11" NumberOfSubmitters="11">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <CitationText>Keskin, M. Personal Communication. 2019. Ankara, Turkey</CitationText>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19481195</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19877176</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25923536</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">27796265</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28969986</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="279" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="6960" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">3M syndrome 2</ElementValue>
                    <XRef ID="MONDO:0013039" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Three M syndrome 2</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">3M2</ElementValue>
                    <XRef Type="MIM" ID="612921" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Three M syndrome is characterized by severe pre- and postnatal growth deficiency (final height 5-6 SD below the mean; i.e., 120-130 cm), characteristic facies, and normal intelligence. Additional features of three M syndrome include short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and loose joints. Males with three M syndrome have hypogonadism and occasionally hypospadias.</Attribute>
                    <XRef ID="NBK1481" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15591" />
                    <XRef ID="15591" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301654</ID>
                    <ID Source="BookShelf">NBK1481</ID>
                  </Citation>
                  <XRef ID="2616" DB="Orphanet" />
                  <XRef ID="C2752041" DB="MedGen" />
                  <XRef ID="MONDO:0013039" DB="MONDO" />
                  <XRef Type="MIM" ID="612921" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA275079" DB="ClinGen" />
          <XRef Type="Allelic variant" ID="610991.0001" DB="OMIM" />
          <XRef Type="rs" ID="762334954" DB="dbSNP" />
          <XRef Type="Interpreted" ID="916539" DB="ClinVar" />
          <XRef Type="Interpreted" ID="998035" DB="ClinVar" />
        </XRefList>
        <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
          <XRef ID="0347" DB="Variation Ontology" />
        </FunctionalConsequence>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00009" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00014" Source="Exome Aggregation Consortium (ExAC)" />
          <AlleleFrequency Value="0.00015" Source="Trans-Omics for Precision Medicine (TOPMed)" />
          <AlleleFrequency Value="0.00016" Source="The Genome Aggregation Database (gnomAD), exomes" />
          <AlleleFrequency Value="0.00024" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <SimpleAllele AlleleID="904871" VariationID="976857">
        <GeneList>
          <Gene Symbol="OBSL1" FullName="obscurin like cytoskeletal adaptor 1" GeneID="23363" HGNC_ID="HGNC:29092" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>2q35</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219547206" stop="219571539" display_start="219547206" display_stop="219571539" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220415449" stop="220436267" display_start="220415449" display_stop="220436267" Strand="-" />
            </Location>
            <OMIM>610991</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_015311.3(OBSL1):c.35dup (p.Cys13fs)</Name>
        <CanonicalSPDI>NC_000002.12:219571197:GGGGGG:GGGGGGG</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>2q35</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="219571197" stop="219571198" display_start="219571197" display_stop="219571198" variantLength="1" positionVCF="219571197" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="220435919" stop="220435920" display_start="220435919" display_stop="220435920" variantLength="1" positionVCF="220435919" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        </Location>
        <ProteinChange>C13fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.220435925dup" Assembly="GRCh37">
              <Expression>NC_000002.11:g.220435925dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.219571203dup" Assembly="GRCh38">
              <Expression>NC_000002.12:g.219571203dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_016977.1" sequenceAccession="NG_016977" sequenceVersion="1" change="g.5349dup">
              <Expression>NG_016977.1:g.5349dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001173408.2" sequenceAccession="NM_001173408" sequenceVersion="2" change="c.35dup">
              <Expression>NM_001173408.2:c.35dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001166879.1" sequenceAccession="NP_001166879" sequenceVersion="1" change="p.Cys13fs">
              <Expression>NP_001166879.1:p.Cys13fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001173431.2" sequenceAccession="NM_001173431" sequenceVersion="2" change="c.35dup">
              <Expression>NM_001173431.2:c.35dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001166902.1" sequenceAccession="NP_001166902" sequenceVersion="1" change="p.Cys13fs">
              <Expression>NP_001166902.1:p.Cys13fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015311.3" sequenceAccession="NM_015311" sequenceVersion="3" change="c.35dup" MANESelect="true">
              <Expression>NM_015311.3:c.35dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_056126.1" sequenceAccession="NP_056126" sequenceVersion="1" change="p.Cys13fs">
              <Expression>NP_056126.1:p.Cys13fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015311.2" sequenceAccession="NM_015311" sequenceVersion="2" change="c.35dup">
              <Expression>NM_015311.2:c.35dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015311.2" sequenceAccession="NM_015311" sequenceVersion="2" change="c.35dupC">
              <Expression>NM_015311.2:c.35dupC</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2023-11-10" DateCreated="2021-09-03" MostRecentSubmission="2024-07-10" NumberOfSubmissions="6" NumberOfSubmitters="6">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic/Likely pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">19481195</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19877176</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33135300</ID>
            </Citation>
            <DescriptionHistory Dated="2022-01-08">
              <Description>Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2021-09-07">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="279" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="6960" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Three M syndrome 2</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">3M syndrome 2</ElementValue>
                    <XRef ID="MONDO:0013039" DB="MONDO" />
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">3M2</ElementValue>
                    <XRef Type="MIM" ID="612921" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Three M syndrome is characterized by severe pre- and postnatal growth deficiency (final height 5-6 SD below the mean; i.e., 120-130 cm), characteristic facies, and normal intelligence. Additional features of three M syndrome include short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and loose joints. Males with three M syndrome have hypogonadism and occasionally hypospadias.</Attribute>
                    <XRef ID="NBK1481" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="15591" />
                    <XRef ID="15591" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301654</ID>
                    <ID Source="BookShelf">NBK1481</ID>
                  </Citation>
                  <XRef ID="2616" DB="Orphanet" />
                  <XRef ID="C2752041" DB="MedGen" />
                  <XRef ID="MONDO:0013039" DB="MONDO" />
                  <XRef Type="MIM" ID="612921" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="916539" DB="ClinVar" />
          <XRef Type="rs" ID="752401295" DB="dbSNP" />
        </XRefList>
        <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
          <XRef ID="0347" DB="Variation Ontology" />
        </FunctionalConsequence>
      </SimpleAllele>
      <Name>NM_015311.3(OBSL1):c.[1273dup];[35dup]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression MANESelect="true">
            <Expression>NM_015311.3:c.[1273dup];[35dup]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_015311.3(OBSL1):c.[1273dup];[35dup] AND 3M syndrome 2" Accession="RCV001260919" Version="4">
        <ClassifiedConditionList TraitSetID="279">
          <ClassifiedCondition DB="MedGen" ID="C2752041">3M syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-04-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-12-03" MostRecentSubmission="2020-12-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="279" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6960" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Three M syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3M syndrome 2</ElementValue>
                <XRef ID="MONDO:0013039" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">3M2</ElementValue>
                <XRef Type="MIM" ID="612921" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Three M syndrome is characterized by severe pre- and postnatal growth deficiency (final height 5-6 SD below the mean; i.e., 120-130 cm), characteristic facies, and normal intelligence. Additional features of three M syndrome include short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and loose joints. Males with three M syndrome have hypogonadism and occasionally hypospadias.</Attribute>
                <XRef ID="NBK1481" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15591" />
                <XRef ID="15591" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301654</ID>
                <ID Source="BookShelf">NBK1481</ID>
              </Citation>
              <XRef ID="2616" DB="Orphanet" />
              <XRef ID="C2752041" DB="MedGen" />
              <XRef ID="MONDO:0013039" DB="MONDO" />
              <XRef Type="MIM" ID="612921" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2640079" SubmissionDate="2020-06-01" DateLastUpdated="2020-12-03" DateCreated="2020-12-03">
        <ClinVarSubmissionID localKey="SUB7282041" submittedAssembly="GRCh37" title="SUB7282041" />
        <ClinVarAccession Accession="SCV001233229" DateUpdated="2020-12-03" DateCreated="2020-12-03" Type="SCV" Version="2" SubmitterName="Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India" OrgID="505991" OrganizationCategory="laboratory" OrgAbbreviation="KMC-MAHE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The sequence variants, c.35dup in exon 1 and c.1273dup in exon 2 of OBSL1 were observed in compound heterozygous state in the proband. Bi-allelic segregation and validation of the variant in the proband and parents were done by Sanger sequencing. These variants were not observed in population databases like gnomAD, 1000 Genomes project, ExAC and in our in-house data of 569 exomes in homozygous state. The novel variant, c.35dup was observed in gnomAD in eleven individuals (allele frequency: 0.00007362) in heterozygous state. The variant, c.1273dup is a known pathogenic variant (Hanson D et al., 2009) for 3M syndrome and is observed in fourty six individuals (allele frequency: 0.0001651) in heterozygous state in gnomAD. Clinical findings observed in the proband are in concordance with 3M syndrome 2. Thus, the above mentioned variants in compound heterozygous state are interpreted to be pathogenic for the clinical findings observed in the proband.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>South Asian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina NextSeq Platform (Illumina, San Diego, California, USA)</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <XRef DB="GTR" ID="GTR000521185.8" Status="current" />
              <Description>Illumina's Nextera Capture Exome Kit followed by massively parallel sequencing on an Illumina NextSeq Platform (Illumina, San Diego, California, USA) was performed. The variant call format (vcf) files were annotated using ANNOVAR followed by integration with OMIM phenotypes, HPO terms and details of allele frequency from in-house database of. Analysis of WES data was performed using the in-house pipeline based on BWA (v0.7.15)16 and GATK best practices (v3.6)17. Popluation databases such as Exome Aggregation Consortium (ExAC), gnomAD and in-house variant database were used to filter the variants with minor allele frequency of &lt;2%. Variants were prioritized using multiple in-silico tools.</Description>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Org: 279559</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2018-07-13" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004322" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0004482" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000325" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000307" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000343" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012471" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000470" Status="current" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000348" Status="current" />
              </Trait>
              <Comment>Clinical findings observed in the proband are in concordance with 3-M syndrome 2.</Comment>
            </TraitSet>
            <Comment>The sequence variants, c.35dup in exon 1 and c.1273dup in exon 2 of OBSL1 were observed in compound heterozygous state in the proband. Bi-allelic segregation and validation of the variant in the proband and her parents were done by Sanger sequencing.</Comment>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="OBSL1">
                <Name>obscurin like cytoskeletal adaptor 1</Name>
              </Gene>
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <GeneLocation>NM_015311.3: exon 1</GeneLocation>
            </Location>
            <XRefList>
              <XRef DB="dbSNP" ID="rs752401295" Status="current" />
            </XRefList>
            <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
              <XRef DB="Variation Ontology" ID="0347" URL="http://purl.obolibrary.org/obo/VariO_0347" />
            </FunctionalConsequence>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015311.3:c.35dup</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="OBSL1">
                <Name>obscurin like cytoskeletal adaptor 1</Name>
              </Gene>
            </GeneList>
            <VariantType>Variation</VariantType>
            <Location>
              <GeneLocation>NM_015311.3: exon 2</GeneLocation>
            </Location>
            <XRefList>
              <XRef DB="dbSNP" ID="rs762334954" Status="current" />
            </XRefList>
            <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
              <XRef DB="Variation Ontology" ID="0347" URL="http://purl.obolibrary.org/obo/VariO_0347" />
            </FunctionalConsequence>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015311.3:c.1273dup</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612921" Status="current" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">19481195</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB7282041</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000307" MappingRef="HP">
        <MedGen CUI="C1844505" Name="Pointed chin" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012471" MappingRef="HP">
        <MedGen CUI="C1836543" Name="Thick vermilion border" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000343" MappingRef="HP">
        <MedGen CUI="C1865014" Name="Long philtrum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004322" MappingRef="HP">
        <MedGen CUI="C0349588" Name="Short stature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Disease" MappingType="XRef" MappingValue="612921" MappingRef="OMIM">
        <MedGen CUI="C2752041" Name="3M syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000348" MappingRef="HP">
        <MedGen CUI="C0239676" Name="High forehead" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004482" MappingRef="HP">
        <MedGen CUI="C1849075" Name="Relative macrocephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000470" MappingRef="HP">
        <MedGen CUI="C0521525" Name="Short neck" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2640079" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000325" MappingRef="HP">
        <MedGen CUI="C1835884" Name="Triangular face" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

